Privia Health Group Inc [PRVA] stock is trading at $24.56, up 2.42%. An important factor to consider is whether the stock is rising or falling in short-term value. The PRVA shares have gain 6.18% over the last week, with a monthly amount drifted -4.55%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Privia Health Group Inc [NASDAQ: PRVA] stock has seen the most recent analyst activity on November 13, 2025, when BMO Capital Markets initiated its Outperform rating and assigned the stock a price target of $30. Previously, Needham started tracking the stock with Buy rating on January 10, 2025, and set its price target to $25. On December 16, 2024, Macquarie initiated with an Outperform rating. KeyBanc Capital Markets started tracking the stock assigning an Overweight rating and suggested a price target of $23 on October 11, 2024. Robert W. Baird initiated its recommendation with an Outperform and recommended $23 as its price target on May 30, 2024. Citigroup started tracking with a Buy rating for this stock on April 22, 2024, and assigned it a price target of $25. In a note dated March 06, 2024, Barclays initiated an Equal Weight rating and provided a target price of $22 on this stock.
Privia Health Group Inc [PRVA] stock has fluctuated between $18.77 and $26.51 over the past year. Currently, Wall Street analysts expect the stock to reach $28.67 within the next 12 months. Privia Health Group Inc [NASDAQ: PRVA] shares were valued at $24.56 at the most recent close of the market. An investor can expect a potential return of 16.73% based on the average PRVA price forecast.
Analyzing the PRVA fundamentals
Privia Health Group Inc [NASDAQ:PRVA] reported sales of 2.04B for the trailing twelve months, which represents a growth of 32.54%. Gross Profit Margin for this corporation currently stands at 0.07% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.03 and Total Capital is 0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 24.19 points at the first support level, and at 23.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 24.96, and for the 2nd resistance point, it is at 25.35.
Ratios To Look Out For
For context, Privia Health Group Inc’s Current Ratio is 1.67. On the other hand, the Quick Ratio is 1.67, and the Cash Ratio is 0.76. Considering the valuation of this stock, the price to sales ratio is 1.48, the price to book ratio is 4.26 and price to earnings (TTM) ratio is 172.96.
Transactions by insiders
Recent insider trading involved Mehrotra Parth, Chief Executive Officer, that happened on May 13 ’25 when 15909.0 shares were sold. Chief Executive Officer, Mehrotra Parth completed a deal on May 12 ’25 to sell 13773.0 shares. Meanwhile, EVP & Chief Financial Officer Mountcastle David sold 3322.0 shares on May 12 ’25.
